NUGGC
gene geneOn this page
Also known as HMFN0672SLIP-GC
Summary
NUGGC (nuclear GTPase, germinal center associated, HGNC:33550) is a protein-coding gene on chromosome 8p21.1, encoding Nuclear GTPase SLIP-GC (Q68CJ6). Nuclear GTPase found in germinal center B-cells, where it may inhibit function of the activation-induced cytidine deaminase AICDA.
Enables GTPase activity. Involved in cellular response to lipopolysaccharide; negative regulation of apoptotic process; and regulation of nuclear cell cycle DNA replication. Located in cytosol and nuclear speck.
Source: NCBI Gene 389643 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 150 total
- MANE Select transcript:
NM_001010906
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33550 |
| Approved symbol | NUGGC |
| Name | nuclear GTPase, germinal center associated |
| Location | 8p21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HMFN0672, SLIP-GC |
| Ensembl gene | ENSG00000189233 |
| Ensembl biotype | protein_coding |
| OMIM | 619088 |
| Entrez | 389643 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000413272, ENST00000418860, ENST00000952401, ENST00000952402
RefSeq mRNA: 1 — MANE Select: NM_001010906
NM_001010906
CCDS: CCDS47833
Canonical transcript exons
ENST00000413272 — 19 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001366794 | 28026962 | 28027052 |
| ENSE00001378623 | 28030310 | 28030418 |
| ENSE00001382143 | 28031243 | 28031381 |
| ENSE00001382566 | 28029266 | 28029402 |
| ENSE00001484699 | 28033540 | 28033697 |
| ENSE00001484701 | 28041051 | 28041215 |
| ENSE00001484703 | 28045527 | 28045660 |
| ENSE00001484704 | 28047507 | 28047612 |
| ENSE00001484705 | 28055965 | 28056054 |
| ENSE00001484707 | 28060426 | 28060601 |
| ENSE00001484709 | 28064522 | 28064731 |
| ENSE00001484710 | 28067514 | 28067744 |
| ENSE00001484713 | 28068216 | 28068438 |
| ENSE00001484716 | 28069544 | 28069652 |
| ENSE00001484718 | 28070252 | 28070356 |
| ENSE00001484722 | 28074368 | 28074456 |
| ENSE00001484724 | 28083775 | 28083936 |
| ENSE00001686259 | 28058258 | 28058276 |
| ENSE00001755704 | 28021964 | 28023462 |
Expression profiles
Bgee: expression breadth broad, 96 present calls, max score 82.84.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.5082 / max 108.0019, expressed in 97 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 92523 | 0.2629 | 80 |
| 92522 | 0.2395 | 70 |
| 92521 | 0.0058 | 2 |
Top tissues by expression
122 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| liver | UBERON:0002107 | 82.84 | gold quality |
| right lobe of liver | UBERON:0001114 | 80.28 | gold quality |
| lymph node | UBERON:0000029 | 79.71 | gold quality |
| bone marrow cell | CL:0002092 | 79.24 | gold quality |
| thymus | UBERON:0002370 | 77.40 | silver quality |
| quadriceps femoris | UBERON:0001377 | 76.86 | gold quality |
| vermiform appendix | UBERON:0001154 | 73.73 | gold quality |
| tonsil | UBERON:0002372 | 72.94 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 72.76 | gold quality |
| cerebellar vermis | UBERON:0004720 | 72.57 | gold quality |
| duodenum | UBERON:0002114 | 66.23 | gold quality |
| bone marrow | UBERON:0002371 | 66.07 | gold quality |
| granulocyte | CL:0000094 | 65.27 | gold quality |
| spleen | UBERON:0002106 | 64.70 | gold quality |
| sural nerve | UBERON:0015488 | 64.39 | gold quality |
| rectum | UBERON:0001052 | 63.72 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 62.71 | gold quality |
| colonic epithelium | UBERON:0000397 | 62.67 | silver quality |
| blood | UBERON:0000178 | 60.26 | gold quality |
| kidney | UBERON:0002113 | 59.74 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 59.33 | gold quality |
| thyroid gland | UBERON:0002046 | 58.47 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 58.31 | gold quality |
| small intestine | UBERON:0002108 | 57.60 | gold quality |
| urinary bladder | UBERON:0001255 | 57.44 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 56.86 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 55.91 | gold quality |
| minor salivary gland | UBERON:0001830 | 55.35 | gold quality |
| transverse colon | UBERON:0001157 | 55.16 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 54.74 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 14.13 |
| E-MTAB-5061 | no | 2.31 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
80 targeting NUGGC, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
Literature-anchored findings (GeneRIF, showing 1)
- SLIP-GC is a replication-related protein in germinal center B cells whose reduction is toxic to cells through an AICDA-dependent mechanism. (PMID:19734146)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | nuggc.3 | ENSDARG00000058672 |
| danio_rerio | nuggc.1 | ENSDARG00000071001 |
| danio_rerio | nuggc.2 | ENSDARG00000091951 |
| danio_rerio | si:dkeyp-85e10.3 | ENSDARG00000092878 |
Protein
Protein identifiers
Nuclear GTPase SLIP-GC — Q68CJ6 (reviewed: Q68CJ6)
Alternative names: Speckled-like pattern in the germinal center
All UniProt accessions (2): C9JSP2, Q68CJ6
UniProt curated annotations — full annotation on UniProt →
Function. Nuclear GTPase found in germinal center B-cells, where it may inhibit function of the activation-induced cytidine deaminase AICDA. Reduces somatic hypermutation in B-cells which may enhance genome stability.
Subcellular location. Nucleus speckle.
Tissue specificity. Expressed in germinal center B-cell and in lymphomas derived from germinal center B-cell.
RefSeq proteins (1): NP_001010906* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR045063 | Dynamin_N | Domain |
| IPR053082 | Nuclear_GTPase_SLIP-GC | Family |
Pfam: PF00350
UniProt features (11 total): sequence variant 5, coiled-coil region 2, chain 1, region of interest 1, compositionally biased region 1, binding site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q68CJ6-F1 | 78.46 | 0.26 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (1): 107–114
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 53 (showing top):
GOBP_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION, GOBP_CELLULAR_RESPONSE_TO_LIPID, GOBP_CELL_CYCLE_DNA_REPLICATION, GOBP_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION, chr8p21, GOBP_REGULATION_OF_CELL_CYCLE, GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_RESPONSE_TO_LIPID, GOBP_REGULATION_OF_CELL_CYCLE_PROCESS, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOBP_DNA_REPLICATION, GOBP_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN, GOCC_NUCLEAR_SPECK
GO Biological Process (3): regulation of nuclear cell cycle DNA replication (GO:0033262), negative regulation of apoptotic process (GO:0043066), cellular response to lipopolysaccharide (GO:0071222)
GO Molecular Function (4): GTPase activity (GO:0003924), GTP binding (GO:0005525), nucleotide binding (GO:0000166), hydrolase activity (GO:0016787)
GO Cellular Component (4): nucleoplasm (GO:0005654), cytosol (GO:0005829), nuclear speck (GO:0016607), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| regulation of cell cycle process | 1 |
| nuclear DNA replication | 1 |
| regulation of DNA-templated DNA replication | 1 |
| apoptotic process | 1 |
| regulation of apoptotic process | 1 |
| negative regulation of programmed cell death | 1 |
| response to lipopolysaccharide | 1 |
| cellular response to molecule of bacterial origin | 1 |
| cellular response to lipid | 1 |
| cellular response to oxygen-containing compound | 1 |
| ribonucleoside triphosphate phosphatase activity | 1 |
| guanyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| catalytic activity | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| nuclear ribonucleoprotein granule | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
832 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NUGGC | NUTM2G | Q5VZR2 | 625 |
| NUGGC | RTL9 | Q8NET4 | 541 |
| NUGGC | RHEX | Q6ZWK4 | 459 |
| NUGGC | MAP7D2 | Q96T17 | 452 |
| NUGGC | RALGPS1 | Q5JS13 | 450 |
| NUGGC | RFTN2 | Q52LD8 | 450 |
| NUGGC | EFR3B | Q9Y2G0 | 420 |
| NUGGC | LAX1 | Q8IWV1 | 416 |
| NUGGC | C16orf54 | Q6UWD8 | 414 |
| NUGGC | AICDA | Q9GZX7 | 385 |
| NUGGC | MANSC1 | Q9H8J5 | 383 |
| NUGGC | ZC3H7B | Q9UGR2 | 374 |
| NUGGC | MS4A1 | P08984 | 374 |
| NUGGC | PDCL2 | Q8N4E4 | 370 |
| NUGGC | RGS13 | O14921 | 366 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NUGGC | POLD2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (3): FEM1B (Affinity Capture-MS), POLD2 (Affinity Capture-MS), NUGGC (Affinity Capture-MS)
ESM2 similar proteins: A1E2I4, A2CI34, A7VK00, D3YWJ0, F1M649, O18412, O95140, P18588, P18589, P18590, P20591, P20592, P33237, Q1MT80, Q20CR4, Q23424, Q28379, Q3UP24, Q4ADG6, Q4ADG7, Q4ADG8, Q4TVR5, Q4VSN1, Q4VSN2, Q4VSN3, Q4VSN4, Q4VSN5, Q5R5G3, Q67E00, Q67E01, Q68CJ6, Q6NVF4, Q6P3V7, Q6Q899, Q6XUX0, Q6XUX1, Q6XUX2, Q6XUX3, Q6ZSC3, Q7YU24
Diamond homologs: D3YWJ0, Q68CJ6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
150 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 114 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3424 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:28026957:TTTA:T | donor_loss | 1.0000 |
| 8:28026958:TTACC:T | donor_loss | 1.0000 |
| 8:28026959:TACCT:T | donor_loss | 1.0000 |
| 8:28026960:ACC:A | donor_loss | 1.0000 |
| 8:28026961:C:CA | donor_loss | 1.0000 |
| 8:28027049:CAGT:C | acceptor_gain | 1.0000 |
| 8:28027051:GT:G | acceptor_gain | 1.0000 |
| 8:28027053:C:CC | acceptor_gain | 1.0000 |
| 8:28027055:A:AC | acceptor_gain | 1.0000 |
| 8:28027055:A:C | acceptor_gain | 1.0000 |
| 8:28030414:CTTAT:C | acceptor_gain | 1.0000 |
| 8:28031238:CGTA:C | donor_loss | 1.0000 |
| 8:28031239:GTAC:G | donor_loss | 1.0000 |
| 8:28031241:ACCT:A | donor_gain | 1.0000 |
| 8:28031242:C:CG | donor_loss | 1.0000 |
| 8:28031242:CCTC:C | donor_gain | 1.0000 |
| 8:28031244:T:TA | donor_gain | 1.0000 |
| 8:28041050:CCA:C | donor_gain | 1.0000 |
| 8:28041216:C:CC | acceptor_gain | 1.0000 |
| 8:28047505:AC:A | donor_gain | 1.0000 |
| 8:28047506:CC:C | donor_gain | 1.0000 |
| 8:28060420:CAATA:C | donor_loss | 1.0000 |
| 8:28060422:ATACC:A | donor_loss | 1.0000 |
| 8:28060423:TACC:T | donor_loss | 1.0000 |
| 8:28060425:C:A | donor_loss | 1.0000 |
| 8:28060598:TGGT:T | acceptor_gain | 1.0000 |
| 8:28064517:GTCAC:G | donor_loss | 1.0000 |
| 8:28064518:TCACC:T | donor_loss | 1.0000 |
| 8:28064519:CACCT:C | donor_loss | 1.0000 |
| 8:28064520:A:C | donor_loss | 1.0000 |
AlphaMissense
5256 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:28030327:A:G | L667P | 0.984 |
| 8:28068430:A:G | L89P | 0.982 |
| 8:28068242:C:G | A152P | 0.981 |
| 8:28033652:A:G | C553R | 0.978 |
| 8:28067741:A:G | W162R | 0.978 |
| 8:28067741:A:T | W162R | 0.978 |
| 8:28045580:C:G | A465P | 0.977 |
| 8:28033658:C:G | A551P | 0.976 |
| 8:28069598:A:G | L68P | 0.973 |
| 8:28033654:A:T | V552D | 0.967 |
| 8:28033674:A:C | F545L | 0.965 |
| 8:28033674:A:T | F545L | 0.965 |
| 8:28033676:A:G | F545L | 0.965 |
| 8:28067728:A:G | L166P | 0.964 |
| 8:28068354:G:C | S114R | 0.964 |
| 8:28068354:G:T | S114R | 0.964 |
| 8:28068356:T:G | S114R | 0.964 |
| 8:28064530:A:G | W305R | 0.963 |
| 8:28064530:A:T | W305R | 0.963 |
| 8:28029311:A:C | F703L | 0.962 |
| 8:28029311:A:T | F703L | 0.962 |
| 8:28029313:A:G | F703L | 0.962 |
| 8:28033650:G:C | C553W | 0.962 |
| 8:28069619:A:G | L61S | 0.959 |
| 8:28069608:A:C | Y65D | 0.958 |
| 8:28023429:A:G | L760P | 0.956 |
| 8:28033639:C:A | G557V | 0.954 |
| 8:28033659:T:A | K550N | 0.954 |
| 8:28033659:T:G | K550N | 0.954 |
| 8:28033663:A:G | L549P | 0.953 |
dbSNP variants (sampled 300 via entrez): RS1000011658 (8:28066348 T>G), RS1000057778 (8:28056136 C>A), RS1000096130 (8:28058327 C>A,G), RS1000138002 (8:28028833 C>A), RS1000173434 (8:28067195 G>T), RS1000308304 (8:28034045 G>A), RS1000367926 (8:28023929 G>A), RS1000518585 (8:28039613 A>G), RS1000531390 (8:28066710 T>A), RS1000564652 (8:28084180 G>A,C,T), RS1000571876 (8:28033760 T>C), RS1000658 (8:28048082 T>C), RS1000692706 (8:28045203 C>T), RS1000698670 (8:28057166 A>T), RS1000743291 (8:28078597 C>A)
Disease associations
OMIM: gene MIM:619088 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001776_4 | Cardiac Troponin-T levels | 4.000000e-06 |
| GCST009030_8 | Venous thromboembolism | 2.000000e-09 |
| GCST010725_67 | Malaria | 1.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005043 | cardiac troponin T measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases mutagenesis, affects methylation, decreases expression | 4 |
| methyleugenol | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| monomethylpropion | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| licochalcone B | increases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Phthalic Acids | decreases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.